Showing results (111-120 of 217) with videos related to

Sort By:
Pageof 22
Oncogene|June 23, 2004
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cellsLiang You, Biao He, Zhidong Xu, et al.
Biochemical and Biophysical Research Communications|March 7, 2006
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesotheliomaSonny Batra, Yihui Shi, Kristopher M Kuchenbecker, et al.
Frontiers in Oncology|August 11, 2018
The Prevention of Brain Metastases in Non-Small Cell Lung Cancer by Prophylactic Cranial IrradiationWillem J A Witlox, Bram L T Ramaekers, Jaap D Zindler, et al.
Frontiers in Oncology|August 1, 2022
Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted RadiomicsSimon A Keek, Manon Beuque, Sergey Primakov, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 studyHaiyan Zeng, Lizza E L Hendriks, Willem J A Witlox, et al.
Translational Lung Cancer Research|April 18, 2025
Connecting the dots: (RANKL+) extracellular vesicle count in blood plasma in relation to bone metastases, skeletal related events and osimertinib treatment in patients with EGFR mutated non-small cell lung cancerAnita J W M Brouns, Iris J Robbesom-van den Berge, Sophie M Ernst, et al.
British Journal of Cancer|June 11, 2024
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancerJudith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 2023
Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitorsFariba Tohidinezhad, Dennis Bontempi, Zhen Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2021
Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie studyNicolas Epaillard, Jose Carlos Benitez, Teresa Gorria, et al.
Respiratory Medicine|January 31, 2023
Integral mediastinal staging in patients with NON-SMALL cell lung cancer and risk factors for occult N2 diseaseCarmen M Lucena, Roberto Martin-Deleon, Marc Boada, et al.
Pageof 22